Date published: 2026-4-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

SNX18 Activators

SNX18 Activators include a diverse array of chemical compounds that, through their influence on various signaling pathways and cellular processes, can indirectly enhance the functional activity of SNX18. SNX18 is a member of the sorting nexin family involved in endocytic membrane trafficking and remodeling. Compounds such as Bisindolylmaleimide I and Wortmannin affect the activity of protein kinase C and PI3K, respectively, which are upstream regulators of pathways that can modulate the availability of binding partners and substrates for SNX18. By inhibiting these kinases, these compounds can enhance the role of SNX18 in endosomal dynamics and membrane trafficking.

Inhibitors of GTPases like Dynasore, ML141, NSC23766, PD 98059, and ZCL278, as well as those affecting actin cytoskeleton regulators like CK-636, IPA-3, SMIFH2, and Y-27632, can alter the actin organization and dynamics, which is crucial for membrane deformation and trafficking processes where SNX18 is actively involved. By modulating the activity of these molecules, the listed compounds can indirectly enhance the functionality of SNX18 in its role in endocytosis and membrane remodeling.

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Bisindolylmaleimide I (GF 109203X)

133052-90-1sc-24003A
sc-24003
1 mg
5 mg
$105.00
$242.00
36
(1)

Bisindolylmaleimide I is a specific inhibitor of protein kinase C (PKC). Inhibition of PKC can enhance SNX18 activity by reducing the competition for binding partners involved in membrane trafficking processes.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin is a potent inhibitor of phosphoinositide 3-kinases (PI3K). By inhibiting PI3K, wortmannin can lead to altered endosomal dynamics, potentially enhancing the membrane remodeling functions of SNX18.

Dynamin Inhibitor I, Dynasore

304448-55-3sc-202592
10 mg
$89.00
44
(2)

Dynasore is a GTPase inhibitor that specifically targets dynamin. By preventing dynamin-mediated vesicle scission, dynasore can enhance the role of SNX18 in membrane tubulation and recycling.

ML 141

71203-35-5sc-362768
sc-362768A
5 mg
25 mg
$137.00
$512.00
7
(1)

ML141 is a selective inhibitor of Cdc42 GTPase. Inhibition of Cdc42 can lead to reduced actin polymerization, thereby potentially enhancing the function of SNX18 in actin-dependent endocytic pathways.

NSC 23766

733767-34-5sc-204823
sc-204823A
10 mg
50 mg
$151.00
$609.00
75
(4)

NSC23766 inhibits Rac1 GTPase. By inhibiting Rac1, this compound can modulate actin organization, which may augment the endocytic trafficking functions where SNX18 is involved.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD 98059 is a MEK inhibitor that indirectly affects the ERK pathway. By modulating this pathway, PD 98059 can influence endosomal sorting and trafficking, processes in which SNX18 plays a crucial role.

IPA 3

42521-82-4sc-204016
sc-204016A
5 mg
50 mg
$94.00
$458.00
6
(1)

IPA-3 is a selective inhibitor of the PAK1 kinase. Inhibiting PAK1 can lead to reduced actin dynamics, potentially increasing the functional activity of SNX18 in membrane remodeling.

SMIFH2

340316-62-3sc-507273
5 mg
$140.00
(0)

SMIFH2 is an inhibitor of the formin family of proteins involved in actin nucleation. Inhibiting formin-dependent actin polymerization may lead to enhanced SNX18 activity in endocytosis.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

Y-27632 is a ROCK inhibitor that modulates actin cytoskeleton dynamics. By inhibiting ROCK, Y-27632 can increase the efficiency of SNX18 in its endocytic trafficking and membrane remodeling roles.

ZCL278

587841-73-4sc-507369
10 mg
$115.00
(0)

ZCL278 is a CDC42 inhibitor that can disrupt actin polymerization. By targeting CDC42, ZCL278 can facilitate the membrane deformation activities mediated by SNX18.